Neuroendocrine Tumors

The symptoms of NETs are highly variable. Some are "functional," meaning they release excess hormones that cause specific syndromes, such as flushing, diarrhea, wheezing, or heart palpitations. Others are "non-functional" and may cause symptoms only when they grow large enough to compress adjacent organs or tissues. This can lead to abdominal pain, unexplained weight loss, or bowel obstruction. Due to this non-specific presentation, NETs are often misdiagnosed or discovered incidentally during tests for other conditions.

While the exact cause of most neuroendocrine tumors remains unknown, there are several recognized risk factors. Genetic predisposition plays a significant role; individuals with hereditary syndromes such as Multiple Endocrine Neoplasia type 1 (MEN1), Neurofibromatosis type 1, or Tuberous Sclerosis are at a substantially higher risk. Additionally, certain chronic conditions affecting the stomach or pancreas can predispose individuals to specific types of NETs. Advanced age is also a general risk factor, though these tumors can manifest at any stage of life.

Diagnosing NETs requires a multi-faceted approach. Physicians often use blood and urine tests to detect elevated levels of specific hormones or markers (such as Chromogranin A or 5-HIAA). Imaging techniques are critical for localizing these tumors, including specialized scans like Ga-68 DOTATATE PET/CT, which are highly sensitive to neuroendocrine tissue. Once localized, a biopsy is typically required to confirm the tumor's biology and grade. A multidisciplinary assessment is then essential to decide between surgical resection, medical therapy, or targeted nuclear medicine approaches.